Lincomycin [Susceptibility] by Disk diffusion (KB)   300-4

LOINC Code


LOINC code300-4
nameLincomycin [Susceptibility] by Disk diffusion (KB)
statusACTIVE

Fully-Specified Name

componentLincomycin
propertySusc  =  Susceptibility
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemIsolate
scaleOrdQn  =  Quantitative or Ordinal:  Test can be reported as either Ord or Qn, e.g., an antimicrobial susceptibility that can be reported as resistant, intermediate, susceptible or as the mm diameter of the inhibition zone. We discourage the use of OrdQn in other circumstances.
methodAgar diffusion

Additional Names

short nameLincomycin Islt KB

Basic Attributes

classABXBACT
type1  Laboratory
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Groups

LG41067-6LincomycinSusc|Isolate

Member of these Panels

50546-1Bacterial susceptibility panel by Disk diffusion (KB)

History/Usage

first released
last updated2.19
last change typeMIN  - change to field other than name

Related Names

Albiotic
ANTIBIOTIC SUSCEPTIBILITIES
AST
c115
Cillimicina
Cillimycin
Disk diffusion
ID
Infectious Disease
InfectiousDisease
Islt
Isol
KB
Kirby-bauer
Lincocin
Lincocine
Point in time
Random
Sus
Suscept
Susceptibilities
Susceptibility
Susceptibilty

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.